Evaluation of dupilumab and benralizumab on peripheral airway resistance and reactance

Documenti analoghi

• Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease
  di: Kirsten E. Stewart, et al.
  Pubblicazione: (2024)
• Indirect case‐matched comparison of anti‐ IL4Rα versus anti‐ IL5Rα on airway hyperresponsiveness
  di: Rory Chan, et al.
  Pubblicazione: (2024)
• Onset and Offset of Early Dupilumab Response Using Domiciliary Monitoring in Type 2 High Unified Airway Disease
  di: Kirsten Stewart, et al.
  Pubblicazione: (2024)
• Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma
  di: Kirsten E. Stewart, et al.
  Pubblicazione: (2025)
• Real‐Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry
  di: Robert Greig, et al.
  Pubblicazione: (2025)